UK re­search cam­pus ex­pands; FDA clears NGS test for tu­mors; Or­p­hazyme rais­es €80 mil­lion IPO

→ One of the lead­ing bio­science hubs for R&D in the UK, Babra­ham Re­search Cam­pus, got the OK from city plan­ners to add two new build­ings as part of an ex­pan­sion fund­ed by life sci­ence prop­er­ty gi­ant Bio­Med Re­al­ty. Ear­li­er this year, Bio­Med an­nounced it would make a £35 mil­lion in­vest­ment in the cam­pus to build 108,000 square-feet of lab and of­fice space called Bio­Med @ Babra­ham. The re­search cam­pus al­ready has about 1,200 work­ers and 60 ear­ly-stage life sci­ence com­pa­nies on cam­pus, along with the bio­med­ical re­search cen­ter Babra­ham In­sti­tute. The new build­ings will sup­port grow­ing com­pa­nies that want to re­main part of the Babra­ham Re­search Cam­pus com­mu­ni­ty, but need a larg­er space than are cur­rent­ly avail­able. Once the project is fin­ished, it will bring San Diego-based Bio­Med Re­al­ty’s to­tal pres­ence in Cam­bridge, UK to 860,000 square feet. The ex­pan­sion is due for com­ple­tion in 2019.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.